Christopher Kellner

Title: Christopher Kellner: Innovator in Brain Biomodulation

Introduction

Christopher Kellner is a notable inventor based in New York, NY (US). He has made significant contributions to the field of brain biomodulation through his innovative patent. His work focuses on developing advanced medical devices that can enhance patient care and treatment outcomes.

Latest Patents

Kellner holds a patent for an "Implantable device and method of brain biomodulation." This invention features an intracranial photobiomodulation system (IPS) that includes a removable light therapy implant and a permanent sheath. The removable light therapy implant is designed to be securely attached to the sheath and consists of a support arm with a proximal end and a distal end, along with at least one light source. This light source is engineered to emit light at various wavelengths and intensities. The permanent sheath is constructed with a shell that is permanently affixed to a patient's scalp, while the sleeve is made of a transparent material that allows light to pass through. The sleeve has a proximal opening to receive the support arm and light source of the removable light therapy implant.

Career Highlights

Kellner is affiliated with the Icahn School of Medicine at Mount Sinai, where he continues to advance his research and development efforts. His work is pivotal in the realm of medical technology, particularly in the treatment of neurological conditions.

Collaborations

Some of his notable coworkers include Alexis Bruhat and Turner Baker, who contribute to the collaborative environment that fosters innovation and research excellence.

Conclusion

Christopher Kellner's contributions to brain biomodulation through his patented inventions highlight his role as a leading innovator in medical technology. His work at the Icahn School of Medicine at Mount Sinai continues to pave the way for advancements in patient care.